Cargando…
Compassionate use of cell products
Autores principales: | de Santis, Gil Cunha, Ubiali, Eugênia Maria Amorim, Covas, Dimas Tadeu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Hematologia e
Hemoterapia
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672125/ https://www.ncbi.nlm.nih.gov/pubmed/23741193 http://dx.doi.org/10.5581/1516-8484.20130036 |
Ejemplares similares
-
Mobilizing hematopoietic progenitor cells in donors with sickle cell trait is safe
por: De Santis, Gil Cunha, et al.
Publicado: (2019) -
Guidelines on transfusion of red blood cells: Prognosis of patients who decline blood transfusions
por: Langhi, Dante Mário, et al.
Publicado: (2018) -
Viral metagenomics in blood donors with post-donation diseases and negative tests for dengue and Zika viruses RNA detection during a major outbreak of arboviruses in Sao Paulo State in 2016
por: Bezerra, Rafael dos Santos, et al.
Publicado: (2020) -
Zika virus and its implication in transfusion safety
por: Kashima, Simone, et al.
Publicado: (2016) -
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VI: Accreditation process
por: De Santis, Gil Cunha, et al.
Publicado: (2021)